CFA Institute's Giving Voice to Values Course

Alongside his roles as the CEO and chief investment officer with the hedge fund Granite Point Capital, Warren Lammert is the chairman of Tevard Biosciences and Cerebral Therapeutics. In addition to these endeavors, Warren Lammert is a CFA® charterholder.

The CFA Institute is an advocacy and educational organization for investment professionals. In addition to developing ethical standards and practices for the field, the Institute organizes industry-recognized training programs focusing on exams and professional development.

Giving Voice to Values (GVV) is a credit-bearing continuing education course that educates investment professionals on how to conduct and lead their businesses in an ethical and value-aligned manner.

Content and curriculum for the course were developed by Darden School of Business professor and ethics expert Mary C. Gentile. The GVV offers an action-focused and practical approach to making ethical decisions in a variety of real-world settings. Participants will learn how to stand up for their beliefs in challenging professional situations.

A Look at the Book Wizards of Wall Street

Possessing more than three decades of experience in the financial industry, Warren Lammert founded Granite Point Capital in 2004. Due to his extensive background in investing, Warren Lammert was asked to be featured in the book Wizards of Wall Street: Market-Beating Insights and Strategies from the World’s Top Performing Mutual Fund Managers, authored by Kirk Kazanjian.

In the book, Kazanjian profiles 18 notable investment executives from around the world. Published in 2000, Wizards of Wall Street offers insights gleaned from one-on-one interviews. The book provides an in-depth examination of the careers of these financial professionals and the qualities that they share. Featuring a question-and-answer format, Wizards of Wall Street concentrates on their unique styles and backgrounds.

Kirk Kazanjian is a personal finance author and mutual fund analyst who has written approximately two-dozen books. He has been interviewed by Bloomberg and CNBC. In addition, he has been featured in a number of business publications such as Fortune and Entrepreneur.

CFA Exams Postponed until at Least December 2020

Warren Lammert leverages more than 30 years of investment management experience to serve as the CEO and chief investment officer of Granite Point Capital in Boston, Massachusetts. In addition to his extensive experience, Warren Lammert is a CFA® charterholder.

Like many other agencies and businesses worldwide, the CFA Institute is taking action to protect its employees and stakeholders during the COVID-19 pandemic. One of these actions is the postponement of the June 2020 CFA Exam. More than 245,000 candidates around the world were registered to take the exam, but now their registration will transfer to one of two later examinations. While the CFA Institute has yet to confirm an exact date for the exams, December 2020 is the earliest possible opportunity.

Those who aspire to become CFA® charterholders must pass three levels of the exam. The first level involves 240 multiple-choice questions. All three levels are split into morning and afternoon sessions, both three hours long. The December 2020 exam is set to be the last paper-based exam for Level I candidates as all further exams will be administered online.

Yale Researchers Search for Solutions to Break the Cycle of Poverty

Based in Boston, Warren Lammert is the founder, chief executive officer, and chief investment officer of Granite Point Capital. Warren Lammert prepared for his career in the financial industry with a bachelor’s degree in economics from Yale University.

A research team led by Yale economics professor Costas Meghir is examining early childhood intervention in Odisha, an Indian state, with the goal of helping children in need in the community to reach their potential and to prevent poverty from being transmitted from one generation to another. Researchers are examining whether an educational intervention that has proven effective on a small scale can be broadened into a policy that could potentially help hundreds of children.

An intervention that was originally conducted in Jamaica featured a curriculum of language development and play activities that were delivered to malnourished children through home visits. Ultimately, when the children received interventions, their outcomes improved significantly.

The project in India involves 1,200 children, many of whom live in communities that lack running water and sanitation. In addition, the children face the possibility of contracting diseases such as dysentery that could affect their growth and lead to anemia. The researchers are seeking a parental intervention. Essentially, they want to encourage parents to undertake routine daily tasks to foster their children’s development, amid their other commitments. The hope is that parents will dedicate their scant time and resources to helping their children.

A Primer on Venture Capital

The recipient of a bachelor's degree in economics from Yale University, Warren Lammert serves as a member of the board of Engage Therapeutics and as the CEO and chief investment officer at Granite Point Capital in Boston, Massachusetts. In addition to these endeavors, Warren Lammert has an interest in financial topics such as venture capital.

Venture capital deals are typically facilitated by angel investors, who are usually high-net-worth individuals, or venture capital firms and involve start-up companies that hold promise in emerging industries. Generally, venture capital can be offered at various stages of a company’s growth.

Often, venture capital deals are attractive to investors because, in return for their investment, they receive a percentage of ownership in the company and have a say in all business decisions. Venture capital firms or angel investors own less than 50 percent of a particular company and often choose to spread their investments around to different companies to mitigate risk.

Pfizer’s Golden Ticket Program Funds Innovative Research

In addition to his career as the founder, CEO, and chief investment officer of Granite Point Capital, Warren Lammert has been actively involved in the biopharmaceutical industry. Warren Lammert is the chairman and co-founder of Tevard Biosciences, a Boston-based gene therapy company. In 2018, Tevard’s gene therapy technique for Dravet syndrome received a “Golden Ticket” in the inaugural year of Pfizer’s Golden Ticket Program.

Pfizer partnered with nonprofit startup incubator LabCentral to provide promising early-stage life sciences companies with the resources they need to accelerate their discoveries. The award program is part of Pfizer’s $150 million investment in entrepreneurial neuroscience companies. Golden Ticket winners receive a free year of LabCentral residence for one of their scientists.

The award includes access to not only state-of-the-art lab equipment and space, but also maintenance services. The Golden Ticket Award is open to companies throughout the United States, and out-of-state winners can also use it to relocate to LabCentral’s headquarters in Cambridge, Massachusetts, which is a biotech hub. In 2019, Pfizer awarded two therapeutics companies investigating treatments for autoimmune disease and fibrosis.

A Primer on Venture Capital

Warren Lammert is an experienced finance professional who has worked as a chief investment officer at Granite Point Capital in Boston, Massachusetts, since 2004. Outside of his endeavors at Granite Point Capital, Warren Lammert possesses an interest in various aspects of the financial industry, such as venture capital.

A subset of private equity, venture capital represents a specific type of financing that investors offer to startups and other types of small businesses. Typically, venture capital is provided by investment banks, individual investors, and financial institutions. Venture capital funding has become a popular way for new companies to raise capital, particularly if they do not have access to bank loans or capital markets. In addition to providing funding for emerging companies, venture capitalists often draw on their experience to offer advice to entrepreneurs on managing new enterprises.

Venture capital traces its roots to the 19th century. After World War II, venture capital emerged as an industry. Georges Doriot, a former professor with the Harvard Business School, is frequently considered to the be the “Father of Venture Capital.” In 1946, he started the American Research and Development Corporation, which became the world’s first publicly owned venture capital firm.